Peter den Heijer

Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) CoreValve ReValving System: results from the multicentre, expanded evaluation registry 1-year following CE mark approval

Nicolò Piazza, Eberhard Grube, Ulrich Gerckens et al. · EuroIntervention · 2008 · 629 citations

Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial

Daniel J.F.M. Thuijs, A. Pieter Kappetein, Patrick W. Serruys et al. · The Lancet · 2019 · 618 citations · Full text

Percutaneous Coronary Intervention, Controlled Syntax Trial, Endovascular Technique +8

Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent (COMPARE II): a randomised, controlled, non-inferiority trial

Pieter C. Smits, Sjoerd H. Hofma, Mario Togni et al. · The Lancet · 2013 · 289 citations

Compare Ii, Vascular Surgery, Lumen-apposing Metal Stent +6

Quality of Life after PCI with Drug-Eluting Stents or Coronary-Artery Bypass Surgery

David J. Cohen, Ben van Hout, Patrick W. Serruys et al. · New England Journal of Medicine · 2011 · 284 citations · Full text

Left Bundle-Branch Block Induced by Transcatheter Aortic Valve Implantation Increases Risk of Death

Patrick Houthuizen, Leen van Garsse, Thomas T. Poels et al. · Circulation · 2012 · 277 citations · Full text